Grupo Somar

The commitment to innovation drives the pharmaceutical firm to continue improving lives, which is why it is working on the launch of 12 new health solutions in a period of 18 months.

Endo International plc (NASDAQ: ENDP) announced on July 5, 2017 that is signed a definitive agreement for the sale of Mexico City based Grupo Farmaceutico Somar